Literature DB >> 25016845

Payers consider waiting out budget-busting hepatitis C drug.

John Carroll.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25016845

Source DB:  PubMed          Journal:  Manag Care        ISSN： 1062-3388


× No keyword cloud information.
  2 in total

1.  Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C.

Authors:  Alena M Pfeil; Oliver Reich; Ines M Guerra; Sandrine Cure; Francesco Negro; Beat Müllhaupt; Daniel Lavanchy; Matthias Schwenkglenks
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

2.  Incidence of Hepatitis C Virus and Other Bloodborne Virus Infections Among Nonurban Residents of Fairfield and New Haven Counties, Connecticut Who Inject Drugs.

Authors:  Samantha H Batman; Lauretta E Grau; Robert Heimer
Journal:  Conn Med       Date:  2018-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.